Aclarion (NASDAQ:ACON – Get Free Report) and Health Catalyst (NASDAQ:HCAT – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability.
Institutional & Insider Ownership
7.5% of Aclarion shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 0.0% of Aclarion shares are held by company insiders. Comparatively, 19.4% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Risk and Volatility
Aclarion has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aclarion | 1 | 0 | 1 | 0 | 2.00 |
| Health Catalyst | 1 | 7 | 3 | 0 | 2.18 |
Aclarion presently has a consensus target price of $7.50, indicating a potential upside of 215.13%. Health Catalyst has a consensus target price of $2.45, indicating a potential upside of 40.00%. Given Aclarion’s higher possible upside, research analysts plainly believe Aclarion is more favorable than Health Catalyst.
Profitability
This table compares Aclarion and Health Catalyst’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aclarion | -10,948.81% | -59.34% | -56.12% |
| Health Catalyst | -90.61% | -1.83% | -0.80% |
Valuation & Earnings
This table compares Aclarion and Health Catalyst”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aclarion | $80,000.00 | 85.68 | -$7.23 million | ($7.40) | -0.32 |
| Health Catalyst | $311.14 million | 0.42 | -$177.97 million | ($3.68) | -0.48 |
Aclarion has higher earnings, but lower revenue than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.
Summary
Health Catalyst beats Aclarion on 10 of the 14 factors compared between the two stocks.
About Aclarion
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
About Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
